These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10554561)

  • 1. [Clinical effect of arotinolol hydrochloride and its influence on renal function in elderly patients with essential hypertension].
    Miyauchi E; Matsumoto M; Kimura Y; Hattori H; Tsukio Y; Tsuchiya H; Takasaki M; Munehira J; Yamada K; Iwai K; Kawanishi K; Hoshino T; Murai H
    Nihon Ronen Igakkai Zasshi; 1999 Aug; 36(8):542-6. PubMed ID: 10554561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J; Handa K; Arakawa K
    Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 4. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
    Perocchio M; Gigli G; Barra M; Sacchetti R; Vallebona A; Rosolen GA; Orlandi S
    Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term carvedilol therapy on renal function in essential hypertension.
    Tomita K; Marumo F
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of arotinolol combined with a different calcium channel blocker in the treatment of Chinese patients with essential hypertension: a one-year follow-up study.
    Fang H; Chen W; Liu X; Xu W
    Clin Exp Hypertens; 2014; 36(8):590-5. PubMed ID: 24678807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term therapy with arotinolol on blood pressure and renal function in hypertensive patients with chronic renal failure.
    Shiigai T
    Clin Ther; 1993; 15(2):330-7. PubMed ID: 7686085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha,beta-blocker, arotinolol chloride, on 24-h blood pressure--difference between elderly and younger hypertensive patients.
    Kuwajima I; Suzuki Y; Otsuka K; Kawamura H; Kuramoto K
    J Clin Pharm Ther; 1993 Aug; 18(4):275-80. PubMed ID: 7693739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha beta-blockers for patients with hypertension].
    Mizuta Y; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():305-9. PubMed ID: 16981560
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of blood pressure and prevention of end-organ damage in patients with accelerated hypertension by combination with arotinolol and extended release nifedipine.
    Suzuki H; Nakamoto H; Nemoto H; Sugahara S; Okada H
    Hypertens Res; 2000 Mar; 23(2):159-66. PubMed ID: 10770263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
    Hara Y; Nakahara H; Miyagishi A; Nakatani H
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine and arotinolol in combination for accelerated-malignant hypertension: results of one year follow-up.
    Nakamoto H; Nemoto H; Sugahara S; Okada H; Suzuki H
    Hypertens Res; 1999 Jul; 22(2):75-80. PubMed ID: 10487322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of arotinolol hydrochloride on hemodynamics, catecholamine levels and metabolism in patients with essential hypertension].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Konishi T; Hamada M; Nakano T
    Kokyu To Junkan; 1988 Mar; 36(3):311-5. PubMed ID: 2453908
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of metoprolol and trichlormethiazide in hypertension.
    Stokkeland OM; Sangvik K; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of arotinolol on insulin sensitivity in obese hypertensive patients.
    Kageyama S; Yamamoto J; Mimura A; Sakurai T; Ishibashi K; Isogai Y
    Clin Ther; 1994; 16(6):981-8. PubMed ID: 7535191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits.
    Nakahara H; Nakazawa M; Tsukada T; Imai S
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):253-63. PubMed ID: 2415080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.